|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Migraine Disorders | |||||
| Heart Disease | |||||
| Cerebrovascular Accident | |||||
| TIA (Transient Ischemic Attack) | |||||
| Vascular Diseases | |||||
| Peripheral Vascular Diseases | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Cerebral Infarction | |||||
| Heart Diseases | |||||
| Ischemic Attack, Transient | |||||
| Stroke | |||||
| 3 | More general conditions related to this trial | ||||
| Brain Diseases | |||||
| Brain Infarction | |||||
| Brain Ischemia | |||||
| Cardiovascular Diseases | |||||
| Central Nervous System Diseases | |||||
| Cerebrovascular Disorders | |||||
| Headache Disorders | |||||
| Headache Disorders, Primary | |||||
| Nervous System Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| MK0974 | |||||
| Comparator: acetaminophen | |||||
| Comparator: Placebo (unspecified) | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Acetaminophen | |||||
| 6 | More general drug interventions related to this trial | ||||
| Analgesics | |||||
| Analgesics, Non-Narcotic | |||||
| Central Nervous System Agents | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Sensory System Agents | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| Merck | |||||